🇺🇸 FDA
Patent

US 10933126

Clostridium difficile immunogenic compositions and methods of use

granted A61KA61K2039/55505A61K2039/55572

Quick answer

US patent 10933126 (Clostridium difficile immunogenic compositions and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/55505, A61K2039/55572, A61K39/08, A61P